Get timely news on our clinical trials and research advancements.
Be the first to know about our webinars, conferences, and investor calls.
Stay informed with communication directly from our team.
Headquartered in Malvern, Pennsylvania, Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients.